Cargando…
Use of funded multicenter prospective longitudinal databases to inform clinical trials in rare diseases—Examination of cholestatic liver disease in Alagille syndrome
The conduct of long‐term conventional randomized clinical trials in rare diseases is very difficult, making evidenced‐based drug development problematic. As a result, real‐world data/evidence are being used more frequently to assess new therapeutic approaches in orphan diseases. In this investigatio...
Autores principales: | Shneider, Benjamin L., Kamath, Binita M., Magee, John C., Goodrich, Nathan P., Loomes, Kathleen M., Ye, Wen, Spino, Cathie, Alonso, Estella M., Molleston, Jean P., Bezerra, Jorge A., Wang, Kasper S., Karpen, Saul J., Horslen, Simon P., Guthery, Stephen L., Rosenthal, Philip, Squires, Robert H., Sokol, Ronald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315119/ https://www.ncbi.nlm.nih.gov/pubmed/35506349 http://dx.doi.org/10.1002/hep4.1970 |
Ejemplares similares
-
Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease
por: Boster, Julia M., et al.
Publicado: (2023) -
Placebo‐Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille Syndrome
por: Shneider, Benjamin L., et al.
Publicado: (2018) -
Unraveling the Relationship Between Itching, Scratch Scales, and Biomarkers in Children With Alagille Syndrome
por: Kamath, Binita M., et al.
Publicado: (2020) -
Impact of long‐term administration of maralixibat on children with cholestasis secondary to Alagille syndrome
por: Shneider, Benjamin L., et al.
Publicado: (2022) -
Outcomes of Childhood Cholestasis in Alagille Syndrome: Results of a Multicenter Observational Study
por: Kamath, Binita M., et al.
Publicado: (2020)